Form 4: Eli Lilly Director Acquires 20 Shares of Common Stock Through Deferral Plan

Sentiment:

SEC Form 4


Director Ralph Alvarez acquired 20 shares of Eli Lilly common stock through a deferral plan, with settlement occurring after separation from service.

Summary

  • Ralph Alvarez, a director at Eli Lilly & Co, acquired 20 shares of common stock on December 18, 2023.
  • The shares were acquired at a price of $579.76 per share.
  • This acquisition was made through the Lilly Directors' Deferral Plan.
  • The shares are deferred in lieu of cash compensation and will be settled in shares of common stock after Mr. Alvarez's separation from service.
  • Following this transaction, Mr. Alvarez beneficially owns 53,872 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

  • The acquisition of shares by a director demonstrates confidence in the company's future.
  • The use of a deferral plan aligns the director's interests with the long-term performance of the company.

Future Outlook

The shares acquired are deferred and will be settled upon the director's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

  • Director stock acquisitions are a common form of compensation in publicly traded companies, aligning director interests with shareholder value.
  • Deferral plans are frequently used to incentivize long-term commitment from directors and executives.
  • The price of $579.76 per share is consistent with the market price of LLY stock at the time of the transaction.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns director interests with the long-term performance of the company.

Key Dates

DateDescription
12/18/2023Date of the stock acquisition by Ralph Alvarez.
12/19/2023Date the SEC Form 4 was signed.

Keywords

Eli Lilly, LLY, Director, Stock Acquisition, Deferral Plan, Common Stock, Beneficial Ownership, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.